After two years of underperformance, Cerebain Biotech Corp (OTCMKTS:CBBT) finds itself flirting with all-time lows having shed more than 80% in market...
Innovation Pharmaceuticals Inc (OTCMKTS:IPIX) embarking on an international expansion drive, for its lead candidate drug, could the spark that will fuel a...
CytoDyn Inc (OYCMKTS:CYDY) is a name that we have covered quite a bit in the past here at Insider Financial. The company’s...
OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has hit rock bottom after plunging to record lows, at the back of a ferocious sell-off. With...
Elite Pharmaceuticals Inc (OTCMKTS:ELTP) is still trading at a discount even on strengthening its pipeline of generic drugs. The company is fresh...
Following a year of bearish outlook on the company’s share price, Biocept Inc (NASDAQ:BIOC) is currently basking in the glory of their...
Microbot Medical Inc (NASDAQ:MBOT) really squeezed the shorts this week. It’s been a while since we’ve seen such a short squeeze. The last...
A 90% plus price implosion attests to Immune Pharmaceuticals Inc (OTCMKTS:IMNP) underperformance over the past year. The stock is currently languishing at...
Progressive Care Inc (OTCMKTS:RXMD) has emerged as one of the top plays for investors looking to make money off the opioid crisis in...